Literature DB >> 4604249

Comparison of a new anorectic agent AN 448 with fenfluramine in the treatment of refractory obesity.

R B Goldrick, P J Nestel, N Havenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604249     DOI: 10.5694/j.1326-5377.1974.tb93399.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  4 in total

1.  Double-blind evaluation of mazindol in refractory obesity.

Authors:  R G Smith; J A Innes; J F Munro
Journal:  Br Med J       Date:  1975-08-02

2.  Some effects of mazindol on the metabolism of monoamines in the rat brain [proceedings].

Authors:  K G Charlton; M F Sugrue
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

Review 3.  Anorectic drugs: use in general practice.

Authors:  D Craddock
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 4.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.